Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Neulogy Ventures is a regulated venture capital fund based in Luxembourg, established in 2014. The firm primarily focuses on early-stage technology companies that are either established or operating in Slovakia. With €65 million in assets under management, Neulogy Ventures has built a diverse portfolio of over 30 companies across 10 countries, emphasizing deeptech solutions that address critical challenges in technology, climate change, and healthcare.
The firm operates from multiple locations, including Bratislava, Slovakia, and Luxembourg City. Neulogy Ventures is recognized as one of the most active venture capital firms in Slovakia and Central Europe, particularly in the seed to Series A funding stages. The fund is backed by the European Investment Fund (EIF), which enhances its credibility and access to additional resources.
Since its inception, Neulogy Ventures has achieved notable milestones, including significant investments in innovative startups that contribute to technological advancements and sustainability. The firm’s commitment to supporting mission-driven entrepreneurs positions it as a key player in the European venture capital landscape.
Neulogy Ventures invests in early-stage technology companies, particularly those with innovative solutions in the fields of healthcare, climate, and biotechnology. The firm targets mission-driven entrepreneurs with bold ambitions, providing funding between €200,000 and €3 million. This investment range allows Neulogy Ventures to support startups at various stages of their development, from pre-seed to seed+ (extension) rounds.
The primary geographic focus is on small and medium enterprises (SMEs) established or operating in Slovakia, although the firm has also invested in companies across 10 countries. Neulogy Ventures seeks to partner with entrepreneurs who are addressing significant challenges in technology and climate change, as well as those developing healthcare solutions. The firm values innovative approaches and scalable business models, aiming to create a positive impact in their respective sectors.
Neulogy Ventures has a diverse portfolio of over 30 companies, showcasing its commitment to investing in innovative technology solutions. Notable portfolio companies include:
This portfolio reflects Neulogy Ventures' focus on deeptech and its commitment to addressing pressing global challenges through innovative technology.
Christian Mandl - Managing Partner: Christian has extensive experience in venture capital and technology investments. He has led numerous successful funding rounds and has a strong background in supporting early-stage companies.
Jaroslav Luptak - Partner: Jaroslav specializes in technology and innovation, with a focus on deeptech investments. He has a proven track record of identifying promising startups and guiding them through their growth phases.
David Szedely - Principal: David brings expertise in financial analysis and investment strategy. He plays a key role in evaluating potential investments and supporting portfolio companies.
Martin Smetana - CFO: Martin oversees the financial operations of Neulogy Ventures, ensuring sound financial management and compliance with regulatory requirements.
Terezia Jacova - Investment Manager: Terezia is responsible for managing relationships with portfolio companies and providing operational support to help them achieve their objectives.
To pitch Neulogy Ventures, founders should use the preferred channel of their website at neulogy.vc or email info@neulogy.vc. The pitch deck should include a clear overview of the business, market analysis, financial projections, and the team’s background. Neulogy Ventures typically responds within a few weeks, and warm introductions are encouraged but not mandatory.
In recent months, Neulogy Ventures has continued to expand its portfolio, actively investing in innovative early-stage tech companies. The firm has highlighted its commitment to addressing challenges in technology, climate change, and healthcare through its investments. Specific details on recent investments or exits have not been disclosed, but the firm remains a prominent player in the Slovak and Central European venture capital scene.
Neulogy Ventures has also been involved in discussions about the future of venture capital in Europe, emphasizing the importance of supporting mission-driven entrepreneurs. The firm’s leadership has participated in various industry events, showcasing their portfolio companies and sharing insights on investment trends.
What are Neulogy Ventures' investment criteria?
Neulogy Ventures invests in early-stage technology companies, particularly those in healthcare, climate, and biotech sectors. The firm targets mission-driven entrepreneurs and provides funding between €200,000 and €3 million.
How can I apply or pitch to Neulogy Ventures?
Founders can pitch their ideas through the firm's website at neulogy.vc or by emailing info@neulogy.vc. It is advisable to include a detailed business plan and financial projections in the pitch deck.
What makes Neulogy Ventures different from other VCs?
Neulogy Ventures focuses on mission-driven entrepreneurs and provides not only capital but also strategic support to help portfolio companies scale. Their expertise in technology and innovation enhances the growth potential of their investments.
What is the geographic scope of Neulogy Ventures?
The firm primarily invests in small and medium enterprises (SMEs) established or operating in Slovakia, but it has also invested in companies across 10 countries in Europe.
What is the typical check size for investments?
Neulogy Ventures typically invests between €200,000 and €3 million in its portfolio companies, allowing for flexibility based on the specific needs of each startup.
What kind of post-investment involvement does Neulogy Ventures have?
Neulogy Ventures provides ongoing support to its portfolio companies, leveraging its network of mentors and advisors to assist with strategic decisions and operational challenges.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.